Safety of the APOLLO Onyx delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study
- 1 February 2021
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 13 (10) , 935-941
Abstract
Background Catheter retention and difficulty in retrieval have been observed during embolization of brain arteriovenous malformations (bAVMs) with the Onyx liquid embolic system (Onyx). The Apollo Onyx delivery microcatheter (Apollo) is a single lumen catheter designed for controlled delivery of Onyx into the neurovasculature, with a detachable distal tip to aid catheter retrieval. This study evaluates the safety of the Apollo for delivery of Onyx during embolization of bAVMs. Methods This was a prospective, non-randomized, single-arm, multicenter, post-market study of patients with a bAVM who underwent Onyx embolization with the Apollo between May 2015 and February 2018. The primary endpoint was any catheter-related adverse event (AE) at 30 days, such as unintentional tip detachment or malfunction with clinical sequelae, or retained catheter. Procedure-related AEs (untoward medical occurrence, disease, injury, or clinical signs) and serious AEs (life threatening illness or injury, permanent physiological impairment, hospitalization, or requiring intervention) were also recorded. Results A total of 112 patients were enrolled (mean age 44.1±17.6 years, 56.3% men), and 201 Apollo devices were used in 142 embolization procedures. The mean Spetzler–Martin grade was 2.38. The primary endpoint was not observed (0/112, 0%). The catheter tip detached during 83 (58.5%) procedures, of which 2 (2.4%) were unintentional and did not result in clinical sequelae. At 30 days, procedure related AEs occurred in 26 (23.2%) patients, and procedure-related serious AEs in 12 (10.7%). At 12 months, there were 3 (2.7%) mortalities, including 2 (1.8%) neurological deaths, none of which were device-related. Conclusion This study demonstrates the safety of Apollo for Onyx embolization of bAVMs. Clinical trial registration CNCT02378883.Keywords
Funding Information
- Medrontic, Inc. (NA)
This publication has 35 references indexed in Scilit:
- Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO)European Radiology, 2013
- Critical appraisal of endovascular treatment of brain arteriovenous malformation using Onyx in a series of 92 consecutive patientsActa Neurochirurgica, 2013
- Nidal embolization of brain arteriovenous malformations: rates of cure, partial embolization, and clinical outcomeJournal of Neurosurgery, 2012
- Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment courseJournal of Neurosurgery, 2011
- Over-the-catheter retrieval of a retained microcatheter following Onyx embolization: a technical reportJournal of NeuroInterventional Surgery, 2011
- Microsurgical retrieval of an endovascular microcatheter trapped during Onyx embolization of a cerebral arteriovenous malformationJournal of NeuroInterventional Surgery, 2010
- Brain Arteriovenous Malformation Treatment Using a Combination of Onyx and a New Detachable Tip Microcatheter, SONIC: Short-Term ResultsAmerican Journal of Neuroradiology, 2010
- Embolization of Intracranial Arteriovenous Malformations with Ethylene-Vinyl Alcohol Copolymer (Onyx)American Journal of Neuroradiology, 2008
- PREOPERATIVE EMBOLIZATION OF INTRACRANIAL ARTERIOVENOUS MALFORMATIONS WITH ONYXNeurosurgery, 2007
- Embolization of Arteriovenous Malformations with Onyx: Clinicopathological Experience in 23 PatientsNeurosurgery, 2001